Vancomycin (vancomycin): Reviews and patient testimonials

Vancomycin 1000 mg powder for concentrate for solution for infusion

Vancomycin, administered intravenously, is indicated in the therapy of severe, potentially life-threatening infections due to susceptible gram-positive microorganisms which cannot be treated with or failed to respond to other effective, less toxic antimicrobial medicinal products, such as penicillins and cephalosporins.

Vancomycin should be reserved for that cases where there is a specific indication, to minimize the chance of resistance emerging.

Vancomycin is useful in the treatment of the following severe infections caused by susceptible microorganisms:

- endocarditis,

- infections of bones (osteomyelitis),

- pneumonia,

- soft-tissue infections.

Endocarditis caused by enterococci, Streptococcus viridans or S. bovis should be treated with a combination of vancomycin and an aminoglycoside.

Vancomycin may be used for the perioperative prophylaxis against bacterial endocarditis, in patients at high risk of developing bacterial endocarditis when they undergo major surgical procedures (e.g., cardiac and vascular procedures, etc) and are unable to receive a suitable beta-lactam antibacterial agent.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin 1g powder for concentrate for solution for infusion vials

Vancomycin is indicated in adults, infants, children aged one month to 12 years and adolescents over 12 years.

Vancomycin solution, administered intravenously, is indicated in the therapy of severe, potentially life-threatening infections due to susceptible gram-positive microorganisms which cannot be treated with or failed to or are resistant to other antibiotics such as penicillins and cephalosporins.

Vancomycin should be reserved for those cases where there is a specific indication, to minimize the chance of resistance emerging.

Vancomycin is useful in the treatment of the following severe infections caused by susceptible microorganisms:

• Endocarditis,

• Infections of the bones (osteomyelitis),

• Pneumonia,

• Soft tissue infections.

Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.

Endocarditis caused by enterococci, Streptococcus viridans or S. bovis should be treated with a combination of vancomycin and an aminoglycoside.

Vancomycin may be used for the perioperative prophylaxis against bacterial endocarditis, in patients at high risk of developing bacterial endocarditis when they undergo major surgical procedures (e.g. cardiac and vascular procedures, etc.) and are unable to receive a suitable beta-lactam antibacterial agent.

Oral administration

Since vancomycin is not absorbed from the gastrointestinal tract, a solution of vancomycin powder for infusion after dissolution can be used orally (see section 6.6.) for the treatment of certain intestinal infections:

• Antibiotic induced pseudomembranous colitis (usually involving Clostridium difficile) and

• Staphylococcal enterocolitis.

Parenteral administration of vancomycin is not effective in these cases, but may be used simultaneously if necessary.

Since vancomycin is not absorbed from the gastrointestinal tract, it is not effective by oral administration in systemic infections.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin 1g Powder for Solution for Infusion

Vancomycin is indicated in potentially life-threatening infections which cannot be treated with other effective, less toxic antimicrobial drugs, including the penicillins and cephalosporins.

Vancomycin is useful in the therapy of severe staphylococcal infections in patients who cannot receive or who have failed to respond to the penicillins and cephalosporins, or who have infections with staphylococci resistant to other antibiotics.

Vancomycin is used in the treatment of endocarditis and as prophylaxis against endocarditis in patients at risk from dental or surgical procedures.

Its effectiveness has been documented in other infections due to staphylococci, including osteomyelitis, pneumonia, septicaemia and soft tissue infections.

Vancomycin may be used orally for the treatment of staphylococcal enterocolitis and pseudomembranous colitis due to Clostridium difficile. Parenteral administration of vancomycin is not effective for these indications. Intravenous administration may be used concomitantly if required.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin 500 mg powder for concentrate for solution for infusion

Vancomycin, administered intravenously, is indicated in the therapy of severe, potentially life-threatening infections due to susceptible gram-positive microorganisms which cannot be treated with or failed to respond to other effective, less toxic antimicrobial medicinal products, such as penicillins and cephalosporins.

Vancomycin should be reserved for that cases where there is a specific indication, to minimize the chance of resistance emerging.

Vancomycin is useful in the treatment of the following severe infections caused by susceptible microorganisms:

- endocarditis,

- infections of bones (osteomyelitis),

- pneumonia,

- soft-tissue infections.

Endocarditis caused by enterococci, Streptococcus viridans or S. bovis should be treated with a combination of vancomycin and an aminoglycoside.

Vancomycin may be used for the perioperative prophylaxis against bacterial endocarditis, in patients at high risk of developing bacterial endocarditis when they undergo major surgical procedures (e.g., cardiac and vascular procedures, etc) and are unable to receive a suitable beta-lactam antibacterial agent.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin 500mg powder for concentrate for solution for infusion vials

Vancomycin is indicated in adults, infants, children aged one month to 12 years and adolescents over 12 years.

Vancomycin solution, administered intravenously, is indicated in the therapy of severe, potentially life-threatening infections due to susceptible gram-positive microorganisms which cannot be treated with or failed to or are resistant to other antibiotics such as penicillins and cephalosporins.

Vancomycin should be reserved for those cases where there is a specific indication, to minimize the chance of resistance emerging.

Vancomycin is useful in the treatment of the following severe infections caused by susceptible microorganisms:

• Endocarditis,

• Infections of the bones (osteomyelitis),

• Pneumonia,

• Soft tissue infections.

Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.

Endocarditis caused by enterococci, Streptococcus viridans or S. bovis should be treated with a combination of vancomycin and an aminoglycoside.

Vancomycin may be used for the perioperative prophylaxis against bacterial endocarditis, in patients at high risk of developing bacterial endocarditis when they undergo major surgical procedures (e.g. cardiac and vascular procedures, etc.) and are unable to receive a suitable beta-lactam antibacterial agent.

Oral administration

Since vancomycin is not absorbed from the gastrointestinal tract, a solution of vancomycin powder for infusion after dissolution can be used orally (see section 6.6.) for the treatment of certain intestinal infections:

• Antibiotic induced pseudomembranous colitis (usually involving Clostridium difficile) and

• Staphylococcal enterocolitis.

Parenteral administration of vancomycin is not effective in these cases, but may be used simultaneously if necessary.

Since vancomycin is not absorbed from the gastrointestinal tract, it is not effective by oral administration in systemic infections.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin 500mg Powder for Solution for Infusion

Vancomycin is indicated in potentially life-threatening infections which cannot be treated with other effective, less toxic antimicrobial drugs, including the penicillins and cephalosporins.

Vancomycin is useful in the therapy of severe staphylococcal infections in patients who cannot receive or who have failed to respond to the penicillins and cephalosporins, or who have infections with staphylococci resistant to other antibiotics.

Vancomycin is used in the treatment of endocarditis and as prophylaxis against endocarditis in patients at risk from dental or surgical procedures.

Its effectiveness has been documented in other infections due to staphylococci, including osteomyelitis, pneumonia, septicaemia and soft tissue infections.

Vancomycin may be used orally for the treatment of staphylococcal enterocolitis and pseudomembranous colitis due to Clostridium difficile. Parenteral administration of vancomycin is not effective for these indications. Intravenous administration may be used concomitantly if required.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin Hydrochloride 500 mg and 1 g Powder for Concentrate for Infusion

Intravenous administration

Vancomycin is indicated in all age groups for the treatment of the following infections (see sections 4.2, 4.4 and 5.1):

- complicated skin and soft tissue infections (cSSTI)

- bone and joint infections

- community acquired pneumonia (CAP)

- hospital acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP)

- infective endocarditis

- acute bacterial meningitis

- bacteraemia that occurs in association with, or is suspected to be associated with, any of the above.

Vancomycin is also indicated in all age groups for the perioperative antibacterial prophylaxis in patients that are at high risk of developing bacterial endocarditis when undergoing major surgical procedures.

Oral administration

Vancomycin is indicated in all age groups for the treatment of Clostridium difficile infection (CDI) (see sections 4.2, 4.4 and 5.1).

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin Powder for Infusion 1g

Intravenous vancomycin is indicated in the following severe infections caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins.

- endocarditis

- infections of the bones (osteomyelitis)

- pneumonia

- soft-tissue infections

Endocarditis caused by enterococci, Streptococcus viridans or S. bovis should be treated with a combination of vancomycin and an aminoglycoside.

Vancomycin may be used for the perioperative prophylaxis against bacterial endocarditis, in patients at high risk of developing bacterial endocarditis when they undergo major surgical procedures (e.g., cardiac and vascular procedures, etc) and are unable to receive a suitable beta-lactam antibacterial agent.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin may be used orally for the treatment of staphylococcal enterocolitis and pseudomembranous colitis due to Clostridium difficile. Parenteral administration of vancomycin is not effective for these indications. Intravenous administration may be used concomitantly if required.

Vancomycin Powder for Infusion 500mg

Intravenous vancomycin is indicated in the following severe infections caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins.

- endocarditis

- infections of the bones (osteomyelitis)

- pneumonia

- soft-tissue infections

Endocarditis caused by enterococci, Streptococcus viridans or S. bovis should be treated with a combination of vancomycin and an aminoglycoside.

Vancomycin may be used for the perioperative prophylaxis against bacterial endocarditis, in patients at high risk of developing bacterial endocarditis when they undergo major surgical procedures (e.g., cardiac and vascular procedures, etc) and are unable to receive a suitable beta-lactam antibacterial agent.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin may be used orally for the treatment of staphylococcal enterocolitis and pseudomembranous colitis due to Clostridium difficile. Parenteral administration of vancomycin is not effective for these indications. Intravenous administration may be used concomitantly if required.

Vancomycin, 1000 mg, powder for solution for infusion

Vancomycin solution, used intravenously is indicated in the therapy of severe, potentially life-threatening infections due to susceptible gram-positive microorganisms which cannot be treated with or failed to respond to other effective, less toxic antimicrobial medicinal products, such as penicillins and cephalosporins.

Vancomycin should be reserved for those cases where there is a specific indication, to minimize the chance of resistance emerging.

Vancomycin is useful in the treatment of the following severe infections caused by susceptible microorganisms:

- endocarditis,

- infections of bones (osteomyelitis),

- pneumonia,

- soft-tissue infections.

Endocarditis caused by enterococci, Streptococcus viridans or S. bovis should be treated with a combination of vancomycin and an aminoglycoside.

Vancomycin may be used for the perioperative prophylaxis against bacterial endocarditis, in patients at high risk of developing bacterial endocarditis when they undergo major surgical procedures (e.g., cardiac and vascular procedures, etc) and are unable to receive a suitable beta-lactam antibacterial agent.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Vancomycin, 500 mg, powder for solution for infusion

Vancomycin solution, used intravenously is indicated in the therapy of severe, potentially life-threatening infections due to susceptible gram-positive microorganisms which cannot be treated with or failed to respond to other effective, less toxic antimicrobial medicinal products, such as penicillins and cephalosporins.

Vancomycin should be reserved for those cases where there is a specific indication, to minimize the chance of resistance emerging.

Vancomycin is useful in the treatment of the following severe infections caused by susceptible microorganisms:

- endocarditis,

- infections of bones (osteomyelitis),

- pneumonia,

- soft-tissue infections.

Endocarditis caused by enterococci, Streptococcus viridans or S. bovis should be treated with a combination of vancomycin and an aminoglycoside.

Vancomycin may be used for the perioperative prophylaxis against bacterial endocarditis, in patients at high risk of developing bacterial endocarditis when they undergo major surgical procedures (e.g., cardiac and vascular procedures, etc) and are unable to receive a suitable beta-lactam antibacterial agent.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Route of administration: Injectable
Molecule: vancomycin